• Explore /
  • Poster
  • / Optimal next-generation sequencing (NGS) panel for estimating tumor mutation burden (TMB) and its clinical implication for non-small cell lung cancer (NSCLC).

Optimal next-generation sequencing (NGS) panel for estimating tumor mutation burden (TMB) and its clinical implication for non-small cell lung cancer (NSCLC).

Abstract Poster

Authors

null

Takaya Ikeda

National Cancer Center Hospital East, Kashiwa, Japan

Takaya Ikeda , Hajime Oi , Kiyotaka Yoh , Shingo Matsumoto , Terufumi Kato , Kazumi Nishino , Atsushi Nakamura , Ichiro Nakachi , Jun Sakakibara-Konishi , Haruko Daga , Naoki Furuya , Kageaki Taima , Eiji Iwama , Noriyuki Ebi , Yuji Shibata , Hiroki Izumi , Kaname Nosaki , Yoshitaka Zenke , Koichi Goto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 9097)

DOI

10.1200/JCO.2021.39.15_suppl.9097

Abstract #

9097

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Ethan Burns

First Author: Minh Duc Phan

First Author: Kevin R Reyes

First Author: Lingzhi Hong